• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦素-2548g/a 基因多态性与抗精神病药引起的体重增加的关系:一项荟萃分析研究。

Leptin -2548g/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study.

机构信息

Department of Pharmacy, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, China.

出版信息

Psychiatr Danub. 2014 Jun;26(2):145-51.

PMID:24909251
Abstract

BACKGROUND

The leptin -2548G/A (rs7799039) gene polymorphism has been implicated in susceptibility to antipsychotic-induced weight gain (AIWG), but study results are still controversial. The present meta-analysis was performed to investigate the relationship between the leptin -2548G/A gene polymorphism and AIWG.

METHODS

Electronic databases were searched for eligible articles in English and Chinese and seven separate studies on the association of the leptin -2548G/A gene polymorphism with AIWG were analyzed.

RESULTS

The meta-analysis involved 451 AIWG patients and 568 controls. The pooled odds ratio (OR) and their corresponding 95% confidence interval (CI) were calculated by a fixed or random effect. Overall, our meta-analysis suggests that the leptin -2548G/A gene polymorphism was not significantly associated with AIWG risk under various genetic models. But, in the subgroup analysis by ethnicity, significant association was found between leptin -2548A allele and the AIWG risk in Asian populations under additive, dominant, recessive, and homozygote genetic model. On the contrary, in European populations, the -2548A allele seemed to decrease the risk of AIWG when compared with the -2548G allele under various genetic models, even though they were not statistically significant.

CONCLUSION

Our meta-analysis suggests that the correlation between leptin -2548G/A gene polymorphism and AIWG risk has significant racial differences.

摘要

背景

瘦素-2548G/A(rs7799039)基因多态性与抗精神病药引起的体重增加(AIWG)易感性有关,但研究结果仍存在争议。本荟萃分析旨在探讨瘦素-2548G/A 基因多态性与 AIWG 之间的关系。

方法

检索英文和中文电子数据库中符合条件的文章,并对 7 项关于瘦素-2548G/A 基因多态性与 AIWG 关联的研究进行分析。

结果

荟萃分析共纳入 451 例 AIWG 患者和 568 例对照。采用固定或随机效应模型计算合并优势比(OR)及其相应的 95%置信区间(CI)。总体而言,我们的荟萃分析表明,在各种遗传模型下,瘦素-2548G/A 基因多态性与 AIWG 风险无显著相关性。但是,按种族进行亚组分析时,在加性、显性、隐性和纯合遗传模型下,瘦素-2548A 等位基因与亚洲人群 AIWG 风险之间存在显著关联。相反,在欧洲人群中,与瘦素-2548G 等位基因相比,-2548A 等位基因在各种遗传模型下似乎降低了 AIWG 的风险,尽管这并不具有统计学意义。

结论

本荟萃分析表明,瘦素-2548G/A 基因多态性与 AIWG 风险之间的相关性存在显著的种族差异。

相似文献

1
Leptin -2548g/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study.瘦素-2548g/a 基因多态性与抗精神病药引起的体重增加的关系:一项荟萃分析研究。
Psychiatr Danub. 2014 Jun;26(2):145-51.
2
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.瘦素基因-2548G/A 多态性与抗精神病药引起的体重增加的关联:CATIE 样本分析及荟萃分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109952. doi: 10.1016/j.pnpbp.2020.109952. Epub 2020 Apr 23.
3
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.瘦素和瘦素受体基因多态性与抗精神病药引起的体重增加的相关性研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):134-41. doi: 10.1016/j.pnpbp.2012.03.001. Epub 2012 Mar 8.
4
[Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain].瘦素基因启动子区-2548G/A功能多态性与抗精神病药物所致体重增加的相关性
Zhonghua Yi Xue Za Zhi. 2003 Dec 25;83(24):2119-23.
5
[-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association].瘦素基因启动子区域-2548G/A功能多态性与精神分裂症患者抗精神病药物所致体重增加:基于核心家庭的关联研究
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Apr;33(4):316-20.
6
Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study.抗精神病药物所致体重增加的遗传预测因素:一项病例匹配多基因研究。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Aug;36(8):720-3. doi: 10.3969/j.issn.1672-7347.2011.08.003.
7
Genetics of antipsychotic-induced weight gain: update and current perspectives.抗精神病药引起的体重增加的遗传学:更新和当前观点。
Pharmacogenomics. 2013 Dec;14(16):2067-83. doi: 10.2217/pgs.13.207.
8
Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.使用抗精神病药物患者中LEP和LEPR基因多态性与肥胖的关系
J Clin Psychopharmacol. 2009 Feb;29(1):21-5. doi: 10.1097/JCP.0b013e31819359be.
9
The polymorphism -2548G/A in leptin and severity of chronic obstructive pulmonary disease.瘦素基因-2548G/A 多态性与慢性阻塞性肺疾病严重程度的关系。
Int J Immunogenet. 2011 Feb;38(1):45-50. doi: 10.1111/j.1744-313X.2010.00968.x. Epub 2010 Sep 20.
10
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.TBC1D1基因变异与抗精神病药物所致体重增加相关性的探索性研究
Hum Psychopharmacol. 2013 Mar;28(2):183-7. doi: 10.1002/hup.2288. Epub 2013 Jan 30.

引用本文的文献

1
LEP rs7799039 and LEPR rs1137101 gene variants are not associated with clinical features in patients with metabolic syndrome in the Turkish population.LEP基因的rs7799039和LEPR基因的rs1137101基因变异与土耳其人群代谢综合征患者的临床特征无关。
Lab Med. 2025 Jan 6;56(1):37-43. doi: 10.1093/labmed/lmae061.
2
The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.精神分裂症谱系障碍中基于药物遗传学的精准医学进展与困境:一项系统评价与荟萃分析
J Pers Med. 2023 Mar 4;13(3):471. doi: 10.3390/jpm13030471.
3
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.
犬尿氨酸途径代谢产物与女性精神分裂症患者奥氮平治疗反应的关系:一项纵向研究。
CNS Neurosci Ther. 2022 Oct;28(10):1539-1546. doi: 10.1111/cns.13895. Epub 2022 Jun 29.
4
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children.儿童抗精神病药物所致体重增加及代谢综合征的负担
Front Psychiatry. 2021 Mar 12;12:623681. doi: 10.3389/fpsyt.2021.623681. eCollection 2021.
5
C677T Polymorphism in the Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia.基因中的C677T多态性与精神分裂症患者中利培酮引起的体重增加有关。
Front Psychiatry. 2020 Jul 2;11:617. doi: 10.3389/fpsyt.2020.00617. eCollection 2020.
6
Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs.非典型抗精神病药物所致脂质紊乱相关基因多态性的研究进展
Front Pharmacol. 2020 Feb 4;10:1669. doi: 10.3389/fphar.2019.01669. eCollection 2019.
7
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?瘦素与精神疾病:瘦素在抗精神病药引起的体重增加中起作用吗?
Lipids Health Dis. 2020 Feb 7;19(1):22. doi: 10.1186/s12944-020-01203-z.
8
Association between polymorphisms of and genes and risperidone- or clozapine-induced hyperglycemia.[基因名称1]和[基因名称2]基因多态性与利培酮或氯氮平所致高血糖之间的关联。
Pharmgenomics Pers Med. 2019 Aug 6;12:155-166. doi: 10.2147/PGPM.S210770. eCollection 2019.
9
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.抗精神病药物所致体重增加与治疗益处之间的复杂关系:一项系统综述及对治疗的启示
Front Neurosci. 2018 Jan 22;11:741. doi: 10.3389/fnins.2017.00741. eCollection 2017.
10
TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.TOX 和 ADIPOQ 基因多态性与汉族人群抗精神病药引起的体重增加相关。
Sci Rep. 2017 Mar 22;7:45203. doi: 10.1038/srep45203.